|
|
||||||||
The Journal of Immunology, Vol 156, Issue 4 1601-1608, Copyright © 1996 by American Association of Immunologists
ARTICLES |
H Tanaka, Y Makino, T Miura, F Hirano, K Okamoto, K Komura, Y Sato and I Makino
Second Department of Internal Medicine, Asahikawa Medical College, Japan.
The therapeutic effectiveness of ursodeoxycholic acid (UDCA) for various autoimmune liver diseases strongly indicates that UDCA possesses immunomodulatory activities. Experimental evidence also supports this notion, since, for example, UDCA has been shown to suppress secretion of IL-2, IL-4, and IFN-gamma from activated T lymphocytes, and Ig production from B lymphocytes. To investigate the mechanical background of UDCA-mediated immunomodulation, we asked whether UDCA interacts with the intracellular signal transduction pathway, especially whether it is involved in immunosuppressive glucocorticoid hormone action. For this purpose, we used a cloned Chinese hamster ovary cell line, CHOpMTGR, in which glucocorticoid receptor cDNA was stably integrated. In immunocytochemical analysis, we found that treatment with UDCA promoted the nuclear translocation of the glucocorticoid receptor in a ligand-independent fashion, which was further confirmed by immunoprecipitation assays. Moreover, the translocated glucocorticoid receptor demonstrated sequence-specific DNA binding activity. Transient transfection experiments revealed that treatment of the cells with UDCA marginally enhanced glucocorticoid- responsive gene expression. We also showed that UDCA suppressed IFN- gamma-mediated induction of MHC class II gene expression via the glucocorticoid receptor-mediated pathway. Together, UDCA-dependent promotion of translocation of the glucocorticoid receptor may be associated with, at least in part, its immunomodulatory action through glucocorticoid receptor-mediated gene regulation.
This article has been cited by other articles:
![]() |
S. Sola, J. D. Amaral, P. M. Borralho, R. M. Ramalho, R. E. Castro, M. M. Aranha, C. J. Steer, and C. M. P. Rodrigues Functional Modulation of Nuclear Steroid Receptors by Tauroursodeoxycholic Acid Reduces Amyloid {beta}-Peptide-Induced Apoptosis Mol. Endocrinol., October 1, 2006; 20(10): 2292 - 2303. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Miura, R. Ouchida, N. Yoshikawa, K. Okamoto, Y. Makino, T. Nakamura, C. Morimoto, I. Makino, and H. Tanaka Functional Modulation of the Glucocorticoid Receptor and Suppression of NF-kappa B-dependent Transcription by Ursodeoxycholic Acid J. Biol. Chem., December 7, 2001; 276(50): 47371 - 47378. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Okamoto, H. Tanaka, H. Ogawa, Y. Makino, H. Eguchi, S.-i. Hayashi, N. Yoshikawa, L. Poellinger, K. Umesono, and I. Makino Redox-dependent Regulation of Nuclear Import of the Glucocorticoid Receptor J. Biol. Chem., April 9, 1999; 274(15): 10363 - 10371. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Makino, N. Yoshikawa, K. Okamoto, K. Hirota, J. Yodoi, I. Makino, and H. Tanaka Direct Association with Thioredoxin Allows Redox Regulation of Glucocorticoid Receptor Function J. Biol. Chem., January 29, 1999; 274(5): 3182 - 3188. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Eickelberg, M. Roth, R. Lorx, V. Bruce, J. Rudiger, M. Johnson, and L.-H. Block Ligand-independent Activation of the Glucocorticoid Receptor by beta 2-Adrenergic Receptor Agonists in Primary Human Lung Fibroblasts and Vascular Smooth Muscle Cells J. Biol. Chem., January 8, 1999; 274(2): 1005 - 1010. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Fontes, S. Kanazawa, D. Jean, and B. M. Peterlin Interactions between the Class II Transactivator and CREB Binding Protein Increase Transcription of Major Histocompatibility Complex Class II Genes Mol. Cell. Biol., January 1, 1999; 19(1): 941 - 947. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Crossin, M.-H. Tai, L. A. Krushel, V. P. Mauro, and G. M. Edelman Glucocorticoid receptor pathways are involved in the inhibition of astrocyte proliferation PNAS, March 18, 1997; 94(6): 2687 - 2692. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |